Ability of IDO To Attenuate Liver Injury in α-Galactosylceramide–Induced Hepatitis Model
Open Access
- 15 October 2010
- journal article
- Published by The American Association of Immunologists
- Vol. 185 (8), 4554-4560
- https://doi.org/10.4049/jimmunol.0904173
Abstract
IDO converts tryptophan to l-kynurenine, and it is noted as a relevant molecule in promoting tolerance and suppressing adaptive immunity. In this study, we examined the effect of IDO in α-galactosylceramide (α-GalCer)–induced hepatitis. The increase in IDO expression in the liver of wild-type (WT) mice administered α-GalCer was confirmed by real-time PCR, Western blotting, and IDO immunohistochemical analysis. The serum alanine aminotransferase levels in IDO-knockout (KO) mice after α-GalCer injection significantly increased compared with those in WT mice. 1-Methyl-d-tryptophan also exacerbated liver injury in this murine hepatitis model. In α-GalCer–induced hepatitis models, TNF-α is critical in the development of liver injury. The mRNA expression and protein level of TNF-α in the liver from IDO-KO mice were more enhanced compared with those in WT mice. The phenotypes of intrahepatic lymphocytes from WT mice and IDO-KO mice treated with α-GalCer were analyzed by flow cytometry, and the numbers of CD49b+ and CD11b+ cells were found to have increased in IDO-KO mice. Moreover, as a result of the increase in the number of NK cells and macrophages in the liver of IDO-KO mice injected with α-GalCer, TNF-α secretion in these mice was greater than that in WT mice. Deficiency of IDO exacerbated liver injury in α-GalCer–induced hepatitis. IDO induced by proinflammatory cytokines may decrease the number of TNF-α–producing immune cells in the liver. Thus, IDO may suppress overactive immune response in the α-GalCer–induced hepatitis model.Keywords
This publication has 26 references indexed in Scilit:
- The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated AutoimmunityThe Journal of Immunology, 2009
- Invariant Natural Killer T Cells Suppress the Neutrophil Inflammatory Response in a Mouse Model of Cholestatic Liver DamageGastroenterology, 2009
- Upregulation of indoleamine 2,3‐dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus‐specific cytotoxic T lymphocytes in vivoLiver International, 2009
- Deficiency of Indoleamine 2,3-Dioxygenase Enhances Commensal-Induced Antibody Responses and Protects against Citrobacter rodentium -Induced ColitisInfection and Immunity, 2008
- Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injuryAmerican Journal of Physiology-Renal Physiology, 2008
- Role of V 14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of V 14+ NKT cells promotes the breakage of CTL toleranceInternational Immunology, 2008
- Activation-induced NKT cell hyporesponsiveness protects from α-galactosylceramide hepatitis and is independent of active transregulatory factorsJournal of Leukocyte Biology, 2008
- Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus InfectionJournal of Virology, 2007
- Immune cell proliferation is suppressed by the interferon‐γ‐induced indoleamine 2,3‐dioxygenase expression of fibroblasts populated in collagen gel (FPCG)Journal of Cellular Biochemistry, 2003
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999